| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.
|
Med Phys
|
1994
|
4.50
|
|
2
|
High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein.
|
Cancer Res
|
1998
|
3.56
|
|
3
|
Rhabdomyosarcoma. A new classification scheme related to prognosis.
|
Arch Pathol Lab Med
|
1992
|
2.79
|
|
4
|
Patterns of recurrence in patients with high-grade soft-tissue sarcomas.
|
J Clin Oncol
|
1985
|
1.87
|
|
5
|
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
|
J Clin Invest
|
1983
|
1.59
|
|
6
|
Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum.
|
Surgery
|
1985
|
1.30
|
|
7
|
Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors.
|
Proc Natl Acad Sci U S A
|
1992
|
1.20
|
|
8
|
High-grade soft tissue sarcomas of the extremities.
|
Cancer
|
1986
|
1.18
|
|
9
|
Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.
|
J Clin Oncol
|
1988
|
1.11
|
|
10
|
A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases.
|
Int J Radiat Oncol Biol Phys
|
1997
|
1.06
|
|
11
|
A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk.
|
Cancer
|
1985
|
0.89
|
|
12
|
Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas.
|
J Surg Oncol
|
1989
|
0.87
|
|
13
|
Experimental and clinical studies with intraoperative radiotherapy.
|
Surg Gynecol Obstet
|
1983
|
0.86
|
|
14
|
Health planning for the future: comparative risk assessment of five major lifestyle risk factors: evidence from the Wirral, UK.
|
J Public Health (Oxf)
|
2012
|
0.86
|
|
15
|
A community based study of unmarried & married mothers.
|
Ir J Med Sci
|
1988
|
0.86
|
|
16
|
Angiosarcoma of the head and neck managed by a combination of multiple biopsies to determine tumor margin and radiation therapy. Report of three cases and review of the literature.
|
Dermatol Surg
|
1998
|
0.85
|
|
17
|
Determinants of radiosensitivity.
|
Semin Oncol
|
1985
|
0.84
|
|
18
|
Oral management of patients following oncology treatment: literature review.
|
Br J Oral Maxillofac Surg
|
2000
|
0.83
|
|
19
|
In vivo incorporation of bromodeoxyuridine into proliferating cells in the marrow and its effects on granulocyte-macrophage progenitor cells.
|
Exp Hematol
|
1985
|
0.82
|
|
20
|
TBI treatment planning using the ADAC pinnacle treatment planning system.
|
Med Dosim
|
2000
|
0.82
|
|
21
|
Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: correlation of liver scan, liver function tests, and plasma CEA with tumor response.
|
Cancer
|
1981
|
0.79
|
|
22
|
Reduction in radiation-induced brain injury by use of pentobarbital or lidocaine protection.
|
J Neurosurg
|
1990
|
0.78
|
|
23
|
Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion.
|
Int J Radiat Oncol Biol Phys
|
1992
|
0.78
|
|
24
|
Treatment of arteriovenous malformations with stereotactic radiosurgery employing both magnetic resonance angiography and standard angiography as a database.
|
Int J Radiat Oncol Biol Phys
|
1993
|
0.77
|
|
25
|
Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.
|
Am J Clin Oncol
|
1987
|
0.77
|
|
26
|
Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications.
|
Int J Radiat Oncol Biol Phys
|
1984
|
0.77
|
|
27
|
Overexpression of a hexa-histidine and T7 peptide-tagged human ribonucleotide reductase small subunit, R2 in Escherichia coli and the generation of human R2 antibodies.
|
Int J Oncol
|
1997
|
0.76
|
|
28
|
Resource utilization. High dose rate versus low dose rate brachytherapy for gynecologic cancer.
|
Am J Clin Oncol
|
1993
|
0.76
|
|
29
|
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha.
|
Adv Exp Med Biol
|
1997
|
0.76
|
|
30
|
The Oral Care Link Nurse: a facilitator and educator for maintaining oral health for patients at the Royal Hospital for neuro-disability.
|
Spec Care Dentist
|
2001
|
0.75
|
|
31
|
Bronchitis symptoms in young teenagers who actively or passively smoke cigarettes.
|
Ir Med J
|
2002
|
0.75
|
|
32
|
A correction method for high-count-rate quantitative radionuclide angiography.
|
Radiology
|
1972
|
0.75
|
|
33
|
4th International Conference on Dose, Time and Fractionation in Radiation Oncology, at the University of Wisconsin, Madison, WI, USA, 16-19 September 1992.
|
Int J Radiat Biol
|
1993
|
0.75
|
|
34
|
Management of cutaneous lymphomas using a multidisciplinary approach.
|
Arch Dermatol
|
1999
|
0.75
|
|
35
|
Tumor induction following intraoperative radiotherapy: late results of the National Cancer Institute canine trials.
|
Int J Radiat Oncol Biol Phys
|
1990
|
0.75
|
|
36
|
Magnetic resonance angiography: a three-dimensional database for assessing arteriovenous malformations. Technical note.
|
J Neurosurg
|
1993
|
0.75
|